These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 32314774

  • 21. Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalization.
    Yellol J, Pérez SA, Yellol G, Zajac J, Donaire A, Vigueras G, Novohradsky V, Janiak C, Brabec V, Ruiz J.
    Chem Commun (Camb); 2016 Dec 01; 52(98):14165-14168. PubMed ID: 27869279
    [Abstract] [Full Text] [Related]

  • 22. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
    Song XD, Kong X, He SF, Chen JX, Sun J, Chen BB, Zhao JW, Mao ZW.
    Eur J Med Chem; 2017 Sep 29; 138():246-254. PubMed ID: 28668477
    [Abstract] [Full Text] [Related]

  • 23. Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies.
    Li J, Guo L, Tian Z, Zhang S, Xu Z, Han Y, Li R, Li Y, Liu Z.
    Inorg Chem; 2018 Nov 05; 57(21):13552-13563. PubMed ID: 30289251
    [Abstract] [Full Text] [Related]

  • 24. Synthesis of mitochondria-targeted coumarin-3-carboxamide fluorescent derivatives: Inhibiting mitochondrial TrxR2 and cell proliferation on breast cancer cells.
    Li Y, Tang Q, Xie Y, He D, Yang K, Zheng L.
    Bioorg Med Chem Lett; 2021 Feb 01; 33():127750. PubMed ID: 33340662
    [Abstract] [Full Text] [Related]

  • 25. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y, Liu B, Xu CX, He L, Wan YC, Ji LN, Mao ZW.
    J Biol Inorg Chem; 2020 Jun 01; 25(4):597-607. PubMed ID: 32232583
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
    Tang B, Wan D, Wang YJ, Yi QY, Guo BH, Liu YJ.
    Eur J Med Chem; 2018 Feb 10; 145():302-314. PubMed ID: 29331753
    [Abstract] [Full Text] [Related]

  • 29. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.
    Ludwig G, Mijatović S, Ranđelović I, Bulatović M, Miljković D, Maksimović-Ivanić D, Korb M, Lang H, Steinborn D, Kaluđerović GN.
    Eur J Med Chem; 2013 Nov 10; 69():216-22. PubMed ID: 24042044
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C, Acuña MI, Busto N, Echevarría I, Martínez-Alonso M, Espino G, García B, Domínguez F.
    Eur J Med Chem; 2018 Sep 05; 157():279-293. PubMed ID: 30099251
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
    Zhang WY, Du F, He M, Bai L, Gu YY, Yang LL, Liu YJ.
    Eur J Med Chem; 2019 Sep 15; 178():390-400. PubMed ID: 31202127
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Mito-methyl coumarin, a novel mitochondria-targeted drug with great antitumor potential was synthesized.
    Wang H, Xu W.
    Biochem Biophys Res Commun; 2017 Jul 15; 489(1):1-7. PubMed ID: 28546001
    [Abstract] [Full Text] [Related]

  • 40. Preparation and the anticancer mechanism of configuration-controlled Fe(II)-Ir(III) heteronuclear metal complexes.
    Shao M, Liu X, Sun Y, Dou S, Chen Q, Yuan XA, Tian L, Liu Z.
    Dalton Trans; 2020 Sep 22; 49(36):12599-12609. PubMed ID: 32857087
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.